Introduction {#s1}
============

Global left ventricular systolic function as measured by left ventricular ejection fraction (LVEF) is a powerful predictor of outcome \[[@R01]-[@R05]\]. The prognostic value of induced wall motion abnormality in patients with coronary artery disease is well established \[[@R06]-[@R12]\]. Regional left ventricular systolic dysfunction as represented by the presence of a resting wall motion abnormality (WMA) is also associated with a higher cardiovascular event rate \[[@R11], [@R13]-[@R19]\]. However, it is unclear whether the prognostic value of the resting WMA relates to the severity of inducible myocardial ischemia or prior infarcts. Our aim was to determine whether regional left ventricular (LV) function on a resting transthoracic echo (TTE) could differentiate those with varying degrees of inducible ischemia and or provide prognostic information in these patients.

Methods {#s2}
=======

Between 2004 - 2009, we identified 503 patients with reversible ischemia on a myocardial SPECT scan (Tc-99m sestamibi) who also had a TTE within 30 days of the scan as part of their routine care at the Massachusetts General Hospital. Using our institution's computerized medical records we obtained baseline information regarding cardiac risk factors and medication. We also evaluated the rate of subsequent revascularization (percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) or death for all patients. The study was approved by the Institutional Review Board at Massachusetts General Hospital.

Transthoracic echocardiography {#s2a}
------------------------------

Two dimensional transthoracic images were acquired in accordance with guidelines published by the American Society of Echocardiography. LVEF was determined using either a modification of the Quinones method \[[@R20]\] or the Biplane methods of discs \[[@R21]\]. The presence, severity and extent of WMA were interpreted by Cardiologists with level III training in echocardiography using a standard segmental model.

Myocardial perfusion imaging {#s2b}
----------------------------

The SPECT- myocardial perfusion images (MPI) images using 99mTc-MIBI or thallium were acquired by a dual-head Siemens gamma camera (E-CAM or C-CAM; Siemens Medical Systems, Erlangen, Germany) in accordance with guidelines published by the American Society of Nuclear Cardiology \[[@R22]\]. Rest and stress myocardial perfusion images (MPI) were analyzed objectively based on the standard 17-segment model in a semi quantitative fashion using commercially available SPECT image analysis program (4DM, Ann Arbor, Michigan) by two physicians with level III training in nuclear cardiology. The parameters analyzed included summed rest score (SRS) reflecting the degree and severity of myocardial scar, summed stress score (SSS) reflecting both the degree and severity of myocardial ischemia and scar, summed difference score (SDS) (derived from SSS - SRS) reflecting the degree and extent of myocardial ischemia using a 5 point scoring system. Myocardial ischemia was categorized as mild when the SDS was 1 to 3, moderate when the SDS was 4 to 7, or severe when the SDS was \> 7. LVEF was derived from gated stress SPECT-MPI, Analyses were performed independently blinded to the results of echocardiography and coronary angiography.

Statistical analysis {#s2c}
--------------------

Unless specified, data are presented as mean values ± SD. The chi-square test was used for categorical variables comparison. Univariate predictors of outcome were calculated with the Cox proportional hazards model. Multivariable analysis was performed using the Cox proportional hazards regression model to identify independent predictors of outcome. All analyses were performed using SPSS statistical software (SPSS Inc., Chicago, Illinois), and p values \< 0.05 (two-tailed) were considered to be statistically significant. The primary end-point was all cause mortality.

Results {#s3}
=======

There were 503 patients who met entry criteria (mean age 69 (SD 11); 79% male). The mean follow-up was 30 months. Baseline characteristics for all patients according to degree of ischemia are presented in [Table 1](#T1){ref-type="table"}, 369 (73%) patients had a normal LVEF, 242 (48%) patients had a WMA. Of the patients with a resting WMA, 126/240 (53%) had an EF ≤ 50%. In patients with no resting WMA 4/259, (2%) had an EF ≤ 50%.The extent of the resting WMA is summarized in [Table 1](#T1){ref-type="table"}. Following the SPECT scan and echo, 246/503 (49%) patients subsequently underwent PCI or CABG. A total of 64/503 (13%) patients died.

###### Baseline Characteristics According to Degree of Ischemia (n = 503)

                                Mild ischemia n = 230 (46%)   Mod /Sev ischemia n = 273 (54%)   P
  ----------------------------- ----------------------------- --------------------------------- ----------
  Mean age (years) (SD)         69 (± 11)                     68 (± 11)                         0.18
  Age \> 65 years               148 (64%)                     165 (60%)                         0.41
  Male gender                   182 (79%)                     215 (79%)                         1.00
  Hypertension                  198 (86%)                     225 (82%)                         0.27
  Hyperlipidemia                187 (81%)                     212 (78%)                         0.19
  Diabetes                      79 (34%)                      85 (31%)                          0.45
  History of smoking            131 (57%)                     168 (62%)                         0.32
  Previous MI                   93 (40%)                      113 (41%)                         0.86
  Previous CVA                  31 (13%)                      25 (9%)                           0.15
  Previous TIA                  8 (3%)                        8 (3%)                            0.80
  PVD                           39 (17%)                      56 (21%)                          0.36
  Chronic renal failure         19 (8%)                       31 (11%)                          0.30
  Mean creatinine (SD)          1.3 mg/dL (± 0.8 mg/dL)       1.3 mg/dL (± 0.7 mg/dL)           0.87
  Dialysis                      5 (2%)                        2 (1%)                            0.26
  Atrial fibrillation/flutter   47 (20%)                      39 (14%)                          0.07
  Prior revascularization       109 (47%)                     110 (40%)                         0.13
  Aspirin                       175 (76%)                     205 (75%)                         0.75
  Clopidogrel                   49 (21%)                      51 (19%)                          0.50
  Warfarin                      33 (14%)                      20 (7%)                           0.01
  Betablocker                   157 (68%)                     177 (65%)                         0.39
  ACE inh/ARB                   125 (54%)                     142 (52%)                         0.59
  Statin                        160 (70%)                     181 (66%)                         0.44
  Diuretic (loop or thiazide)   70 (30%)                      86 (32%)                          0.85
  Aldosterone antagonist        6 (3%)                        6 (2%)                            0.78
  Calcium channel blocker       44 (19%)                      61 (22%)                          0.44
  Digoxin                       16 (7%)                       10 (4%)                           0.11
  Echo                                                                                          
    EF (mean, SD)               58% (14)                      58% (13)                          0.78
    EF \> 50%                   168 (73%)                     201 (74%)                         0.68
    WMA                         115 (50%)                     127 (47%)                         0.47
    ≤ 3 segments                25 (11%)                      21 (9%)                           0.33
    ≤ 6 segments                37 (16%)                      46 (17%)                          0.59
    \> 6 segments               36 (16%)                      42 (15%)                          0.78
    Diffusely hypokinetic       17 (7%)                       18 (7%)                           1.00
  Nuclear                                                                                       
    Summed Rest Score           16 (± 9)                      12 (± 7)                          \< 0.001
    Summed Stress Score         19 (± 9)                      18 (± 7)                          0.53
    Summed Difference Score     3 (± 3)                       7 (± 4)                           \< 0.001
    Revascularization           79 (34%)                      167 (61%)                         \< 0.001
    Death                       31 (13%)                      33 (12%)                          0.69

Degree of ischemia {#s3a}
------------------

A total of 230 (46%) patients had mild ischemia and 273 (54%) had moderate/severe ischemia on a SPECT scan. The summed rest score (SRS) for patients with mild ischemia was 16.2 (± 8.6) compared to 12.0 (± 7.2) for patients with moderate/severe ischemia (P \< 0.001). The summed stress score (SSS) for patients with mild ischemia was 18.9 (± 9.0) compared to 18.4 (± 7.1) for patients with moderate/severe ischemia (P = NS). The summed difference score (SDS) for patients with mild ischemia was 2.8 (± 2.9) compared to 6.6 (± 3.9) for patients with moderate/severe ischemia (P \< 0.001). There was no significant difference in LVEF or WMA between the 2 groups of ischemia. A total of 219/503 (44%) patients had a history of previous revascularization (47% in mild ischemia group V 40% in the moderate/severe ischemia group). The rate of subsequent revascularization was significantly higher in the moderate/severe ischemia group (61% v 34%; P \< 0.001). No significant difference in mortality was observed between the 2 groups of ischemia.

Degree of ischemia and resting WMA {#s3b}
----------------------------------

Groups were then analyzed according to degree of ischemia and the presence or absence of a resting WMA. [Table 2](#T2){ref-type="table"} summarizes the rates of revascularization and death in these 4 groups. As a substantial number of patients had a history of prior revascularization, [Table 3](#T3){ref-type="table"} summarizes rates of subsequent revascularization and death in a subset of patients with no prior history of revascularization.

###### Summary of Revascularization and Outcomes According to Degree of Ischemia and WMAs (n = 503)

  ------------------------- ----------------------------------------------- -------------------------------------------- ---------
                            Mild ischemia and no WMA (n = 115)              Mild ischemia and WMA (n = 115)              P value
  Prior revascularization   50 (43%)                                        59 (51%)                                     0.29
  Revascularization         47 (41%)                                        32 (28%)                                     0.05
  Death                     11 (10%)                                        20 (17%)                                     0.12
                                                                                                                         
                            Moderate/severe ischemia and no WMA (n = 146)   Moderate/severe ischemia and WMA (n = 127)   P value
  Prior revascularization   45 (31%)                                        65 (51%)                                     0.001
  Revascularization         98 (68%)                                        69 (54%)                                     0.03
  Death                     10 (7%)                                         23 (18%)                                     0.005
  ------------------------- ----------------------------------------------- -------------------------------------------- ---------

Eighteen patients who were revascularized subsequently died.

###### Summary of Revascularization and Outcomes According to Degree of Ischemia and WMAs in a Subset of Patients With no History of Prior Revascularization (n = 284)

                      Mild ischemia and no WMA on Echo (n = 65)               Mild ischemia and WMA on Echo (n = 56)              P value
  ------------------- ------------------------------------------------------- --------------------------------------------------- ---------
  Revascularization   30 (46%)                                                20 (36%)                                            0.27
  Death               6 (9%)                                                  10 (18%)                                            0.19
                                                                                                                                  
                      Moderate/severe ischemia and no WMA on Echo (n = 100)   Moderate/severe ischemia and WMA on Echo (n = 63)   P value
  Revascularization   76 (76%)                                                41 (65%)                                            0.22
  Death               6 (6%)                                                  12 (19%)                                            0.01

Ten patients were revascularized and subsequently died.

Patients with no resting WMA had a better prognosis compared with patients with a resting WMA, 21/261 (8%) with no resting WMA died compared to 43/242 (18%) in patients with a resting WMA. In patients with moderate/severe ischemia, the presence of a resting WMA was associated with a higher mortality rate (18% v 7%; P = 0.005). There was no significant difference in mortality in the group with mild ischemia regardless of the presence or absence of a resting WMA. In patients with a resting WMA (n = 242) there was no significant difference in mortality when comparing patients with less or more than 6 segments involved (P = NS). [Table 4](#T4){ref-type="table"} shows the extent of wall motion abnormality on echo represented by the number of abnormal segments and all cause mortality.

###### A. Extent of WMA on Echo According to Segmental Abnormalities and All Cause Mortality (n = 503) P = 0.01 (ANOVA); B. Extent of WMA on Echo According to Segmental Abnormalities and All Cause Mortality in Patients With Mild Ischemia (n = 230) P = 0.39 (ANOVA); C. Extent of WMA on Echo According to Segmental Abnormalities and All Cause Mortality in Patients With Moderate/Severe Ischemia (n = 273) P = 0.005 (ANOVA)

  ------- ------------- -------------- -------------- --------------- ------------------
  A       0 (n = 261)   ≤ 3 (n = 46)   ≤ 6 (n = 83)   \> 6 (n = 78)   Diffuse (n = 35)
  Dead    21 (8%)       6 (13%)        13 (16%)       16 (21%)        8 (23%)
  Alive   240 (92%)     40 (87%)       70 (84%)       62 (79%)        27 (77%)
                                                                      
  B       0 (n = 115)   ≤ 3 (n = 25)   ≤ 6 (n = 37)   \> 6 (n = 36)   Diffuse (n = 17)
  Dead    11 (10%)      5 (20%)        6 (16%)        5 (14%)         4 (24%)
  Alive   104 (90%)     20 (80%)       31 (84%)       31 (86%)        13 (76%)
                                                                      
  C       0 (n = 146)   ≤ 3 (n = 21)   ≤ 6 (n = 46)   \> 6 (n = 42)   Diffuse (n = 18)
  Dead    10 (7%)       1 (5%)         7 (15%)        11 (26%)        4 (22%)
  Alive   136 (93%)     20 (95%)       39 (85%)       31 (74%)        14 (78%)
  ------- ------------- -------------- -------------- --------------- ------------------

In the group with mild ischemia, the LVEF was similar regardless of the presence of a resting WMA. Furthermore, there was no significant difference in mortality between the two groups. Only 2% of patients with mild ischemia and no resting WMA had an LVEF \< 50%. In the group with moderate/severe ischemia, the LVEF was lower in patients with resting WMA as was the mortality rate. Only 1% of patients with moderate/severe ischemia and no resting WMA had LVEF \< 50%.

Univariate analysis {#s3c}
-------------------

[Table 5](#T5){ref-type="table"} summarizes the predictive value of variables for overall mortality in a univariate analysis. Age, history of hypercholesterolemia, cerebrovascular accident (CVA), peripheral vascular disease (PVD), creatinine, LVEF, presence of resting WMA and number of abnormal segments were all predictors of mortality. Sex, history of hypertension, diabetes, smoking, degree of ischemia, SDS, and prior revascularization were not predictors of mortality in this study group.

###### Univariable Analysis

                            HR      P value    95% CI
  ------------------------- ------- ---------- ---------------
  Age                       1.053   \< 0.001   1.027 - 1.081
  Sex                       1.242   0.113      0.950 - 1.625
  Hypertension              0.919   0.639      0.646 - 1.308
  Hypercholesterolemia      1.362   0.021      1.049 - 1.768
  Diabetes                  0.847   0.191      0.660 - 1.087
  CVA                       0.641   0.003      0.480 - 0.856
  PVD                       0.649   0.001      0.503 - 0.838
  History of smoking        0.868   0.584      0.523 - 1.440
  Prior revascularization   0.896   0.660      0.548 - 1.463
  Creatinine                1.293   0.003      1.093 - 1.529
  Echo EF \>/\< 50%         0.339   \< 0.001   0.208 - 0.554
  Resting WMA               0.459   0.003      0.272 - 0.774
  Number of abn segments    1.905   0.013      1.148 - 3.162
  Degree of ischemia        1.102   0.437      0.862 - 1.409
  SDS                       1.003   0.915      0.943 - 1.067

Multivariable analysis {#s3d}
----------------------

Independent predictors of mortality included age (HR 1.0, 95% CI 1.02 - 1.08; P = 0.001), creatinine (HR 1.3, 95% CI 1.08 - 1.67; P = 0.008), hypercholesterolemia (HR 1.7, 95% CI 1.03 - 2.98., P = 0.037), CVA (HR 2.1, 95% CI 1.19 - 3.81, P = 0.011) and PVD (HR 1.7, 95% CI 1.0 - 2.83, P = 0.05). LVEF \< 50% was associated with a HR 2.2 (95% CI 1.34 - 3.68; P = 0.002), however, the presence of a resting WMA, extent of WMA categorized by number of segments (\>/\< 6) and summed stress score were not independent predictors of mortality ([Table 6](#T6){ref-type="table"}).

###### Multivariable Analysis (Forward Conditional Model)

                             HR    P value   95% CI
  -------------------------- ----- --------- -------------
  Age                        1.0   0.001     1.02 - 1.08
  Creatinine                 1.3   0.008     1.08 - 1.67
  Ejection Fraction \< 50%   2.2   0.002     1.34 - 3.68
  Hypercholesterolemia       1.7   0.037     1.03 - 2.98
  CVA                        2.1   0.011     1.19 - 3.81
  PVD                        1.7   0.05      1.00 - 2.83

Discussion {#s4}
==========

Our aim was to determine whether regional left ventricular function, on a resting echo, provided incremental prognostic information in patients with varying degrees of myocardial ischemia. In this study of 503 subjects, there was no significant difference in LVEF and the presence of a resting WMA in patients with mild and moderate/severe ischemia, 64 (13%) of patients died after a mean follow-up of 30 months. The presence of a resting WMA in patients with moderate/severe ischemia was associated with a higher mortality. For those with mild ischemia the presence of a WMA was not associated with differences in outcome.

It is well established that LVEF is an excellent prognostic marker in patients post myocardial infarction \[[@R01]-[@R05]\]. Regional left ventricular function provides additional prognostic information in patients post myocardial infarction \[[@R17], [@R23]\], and in patients with heart failure \[[@R18]\]. Although the presence of a resting WMA generally represents prior infarction, stunned or hibernating myocardium, it may also be found in individuals without coronary artery disease \[[@R13]\]. In a study of 2864 subjects without clinically evident cardiovascular disease, 140 pts (5%) had a resting wall motion abnormality. The cumulative incidences of combined fatal and nonfatal cardiovascular mortality were 2.5 to 3 fold higher in those with segmental wall motion abnormalities compared to those with no resting WMA \[[@R13]\]. In populations without clinical evidence of cardiovascular disease resting WMA can predict abnormal perfusion and ischemia \[[@R24]\]. In patients without known coronary artery disease referred for evaluation of ischemia, 21% had WMA detected on baseline TTE. The prevalence of myocardial perfusion abnormalities was higher in patients with resting WMA (75% v 25%). The presence of a resting WMA was an independent predictor of ischemic response \[[@R24]\].

Some studies have shown that in certain subgroups of patients, resting WMA is a more powerful predictor of cardiovascular events than LVEF in patients after myocardial infarction \[[@R17], [@R19]\]. In a study of 233 patients with diabetes, mean LVEF 52% and negative dobutamine stress echo, resting WMA, unlike LVEF was an independent predictor of future events including death, non-fatal ST-elevation MI, non-ST elevation MI (NSTEMI) and late (\> 6 months) revascularization \[[@R16]\]. In a study of patients with end stage renal failure the presence of both a resting WMA and inducible ischemia on dobutamine stress echo were associated with a higher rate of adverse events. The presence of a fixed WMA alone was not, however, a predictor of major adverse cardiac events (MACE) in this cohort of subjects \[[@R25]\].

Left ventricular global and regional function is closely related and most patients with significant WMAs have a reduced LVEF \[[@R26]\]. LVEF however, reflects global function and hypercontractile segments may offset hypokinetic segments thereby preserving overall LV systolic function. Some studies have reported that resting WMA is a more powerful predictor of outcome \[[@R17]\] whereas others report incremental prognostic information using both resting WMA and LVEF \[[@R18]\]. In our study, 53% with a resting WMA had an EF ≤ 50%, whereas 2% of patients with no resting WMA had an EF ≤ 50%. In all patients, LVEF, the presence of a resting WMA and the number of abnormal segments were all univariate predictors of death during a mean follow-up period of 30 months.

From our retrospective study, it is not possible to determine why patients with moderate/severe inducible ischemia and a WMA on resting echo have a worse prognosis than those without a resting WMA. One could speculate several possible explanations. It is possible that those with a resting WMA not only have had prior infarction but also more severe coronary artery disease. One would expect the resting WMA to impact LVEF which is a strong marker of outcome as seen in our multivariate analysis and prior studies \[[@R26]\].

Limitations of this study {#s4a}
-------------------------

This is a retrospective study with its inherent limitations. The study group represents a select cohort of moderate to high risk patients with documented ischemia on SPECT. Consequently, the results may not be generalizable to other populations.

Summary {#s4b}
-------

The presence of a resting WMA on TTE in patients with moderate and severe ischemia by myocardial perfusion imaging is associated with a higher mortality compared to patients with no resting WMA and moderate/severe ischemia. Regional left ventricular dysfunction, however, unlike LVEF was not an independent predictor of mortality. LV dysfunction whether global or regional is a powerful prognostic marker. Early identification of these high risk patients allows optimization of medical therapy +/- referral for revascularization.
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